malina jasamai, tan bee yoke, adyani md redzuan.  (2024).  complementary and alternative medicine (cam) usage among hypertensive patients : a prospective observational study.  - the african journal of biomedical research.  3525 - 3535. 

sasha muhammed elamin, nur fitrah muhamad arshad, adyani md redzuan, siti azdiah abdul aziz, joyce hong, xin yun chua, bassam saleh bin-abbas, afaf alsagheir, noraida mohamed shah.  (2024).  information needs on type 1 diabetes mellitus (t1dm) and its management in children and adolescents: a qualitative study.  - bmj open.  1-8. 

hock peng koh, adyani md redzuan, shamin mohd saffian, hasnita hassan, jivanraj r. nagarajah, noel thomas ross.  (2023).  mortality outcomes and predictors of failed thrombolysis following stemi thrombolysis in a non-pci capable tertiary hospital: a 5-year analysis.  - internal and emergency medicine.  1169-1180. 

farhana fakhira ismail, adyani md redzuan, wei wen chong, mariani ahmad nizaruddin.  (2023).  role of community pharmacists in cardiovascular diseases-related health promotion and dyslipidemia management in malaysia: a nationwide cross-sectional study.  - plos one.  1-15. 

adyani md redzuan, nur syazwani taridi, farida hanim islahudin, shamin mohd saffian, siti azdiah abdul aziz, mohd makmor bakry, yin mei kuen.  (2023).  assessment of serum digoxin concentration measurement in patients with heart failure and atrial fibrillation.  - malaysian journal of medicine and health sciences.  7. 

fei yee lee, farida islahudin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, mohd makmor-bakry.  (2022).  adverse drug reactions of antihypertensives and cyp3a5*3 polymorphism among chronic kidney disease patients.  - frontiers in pharmacology.  1-8. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  the outcomes of reperfusion therapy with streptokinase versus tenecteplase in st-elevation myocardial infarction (stemi): a propensity-matched retrospective analysis in an asian population.  - international journal of clinical pharmacy.  641-650. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj r. nagarajah, noel thomas ross, hasnita hassan.  (2022).  clinical profile and predictors of 30-day all-cause mortality of stelevation myocardial infarction (stemi) patients receiving fibrinolytic therapy in an asian population.  - heart & lung.  68-76. 

endang kumolosasi, mandy cheong li ching, nuraina athira ahmad salwanizam, nur shamizah ainna muhammad esham, qistina alyani ayob, ramavisithira ramasamy, harishankari govindan, adyani md redzuan, malina jasamai.  (2022).  drug-herb interactions: selected antihypertensive drugs with moringa oleifera leaves extract.  - sains malaysiana.  1143-1154. 

shantini radhakrishnan, salmi abdul razak, mohd shahrir mohamed said, noraida mohamed shah, adyani md redzuan.  (2022).  cardiovascular risks and primary interventions among treated rheumatoid arthritis patients: experience from a tertiary care centre in kuala lumpur, malaysia.  - tropical journal of pharmaceutical research.  863-870. 

hock peng koh, adyani md redzuan, shamin mohd saffian, jivanraj nagarajah, noel thomas ross, hasnita hassan.  (2022).  impact of covid-19 pandemic on stemi thrombolysis and emergency department's performance in a non-pci capable tertiary hospital.  - american journal of emergency medicine.  9-14. 

zainol akbar zainal, shairyzah ahmad hisham, adyani md redzuan, saliha roslan.  (2022).  pharmacy graduates experiences and perception on psychiatry pharmacy experiential learning or clerkship in selangor, malaysia.  - neuroquantology.  3780-3786. 

farizan abdul-ghaffar, adyani md redzuan, mohd makmor-bakry, mohamad arif muhamad nor.  (2022).  drug-related problems in pulmonary hypertension with valvular heart disease.  - therapeutics and clinical risk management.  1069-1079. 

farhana fakhira ismail, adyani md redzuan, chong wei wen.  (2022).  patient-centered education in dyslipidemia management: a systematic review.  - asian biomedicine.  214-236. 

fei yee lee, farida islahudin, aina yazrin ali nasiruddin, abdul halim abdul gafor, hin-seng wong, sunita bavanandan, shamin mohd saffian, adyani md redzuan, nurul ain mohd tahir, mohd makmor-bakry.  (2021).  effects of cyp3a5 polymorphism on rapid progression of chronic kidney disease: a prospective, multicentre study.  - journal of personalized medicine.  1-14. 

adyani md redzuan, kavidha mohan, jivanraj nagarajah.  (2021).  risk factors associated with the occurrence of streptokinase induced hypotension among st elevation myocardial patients (stemi).  - journal of cardiovascular disease research.  1301-1309. 

amutha selvaraj, adyani md redzuan, ernieda hatah.  (2020).  community pharmacists' perceptions, attitudes and barriers towards pharmacist-led minor ailment services in malaysia.  - international journal of clinical pharmacy.  777-785. 

boon tiang lau, mohd makmor bakry, hui jan tan, siew yen ng, adyani md redzuan.  (2020).  patient's practice of complementary and alternative medicine (cam) for the management of epilepsy.  - journal of advanced pharmacy education and research.  1-7. 

adyani md redzuan, alharbi abdulmajeed shoieb alharbi.  (2020).  experience and expectation of healthcare providers towards clinical pharmacy services.  - current trends in biotechnology and pharmacy.  70. 

salmi abdul razak, mohd makmor bakry, mohd shahrir mohamed said, chai-eng tan, adyani md redzuan.  (2020).  development and validation of adherence score for subcutaneous biologic disease-modifying antirheumatic drugs.  - frontiers in pharmacology.  1-9. 

s. b. choo, a. saifulbahri, s. n. zullkifli, m. l. fadzil, a. md. redzuan, n. abdullah, r. s. ahmad bustamam, h. z. ahmad & n. mohamed shah.  (2019).  adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in malaysia.  - climacteric.  . 

malina jasamai, endang kumolosasi, adyani md redzuan.  (2019).  possible drug-herb interactions between merunggai (moringaoleifera) and selected antihypertensive drugs.  - bmc proceedings.  6. 

salmi abdul razak, mohd makmor-bakry, adyani md-redzuan.  (2018).  management of rheumatoid arthritis: special consideration for biologic disease-modifying anti-rheumatic drugs.  - asian journal of pharmaceutical and clinical research.  . 

seham saeed, farida islahudin, mohd makmor-bakry, adyani md redzuan.  (2018).  the practice of complementary and alternative medicine among chronic kidney disease patients.  - journal of advanced pharmacy education and research.  . 

chin, s.-c., redzuan, a.m..  (2017).  effect of combining losartan and perindopril in diabetic patients with proteinuria.  - asian journal of pharmaceutical and clinical research.  357-359. 

chuan-poh lim, adyani md-redzuan, yin-key lai, boekhtiar borhanuddin, fook-choe cheah.  (2017).  a comparison of once- and thrice-weekly erythropoietin dosing for the treatment of anaemia of prematurity.  - annals of the academy of medicine of singapore.  395-398. 

ai sim wee, mohd shahrir bin mohamed said, adyani bt md redzuan.  (2016).  medication adherence status among rheumatoid arthritis patients.  - international journal of pharmacy and pharmaceutical sciences.  317-321. 

siti-zainora mohd-zulkefli, marhanis-salihah omar, adyani md-redzuan.  (2016).  factors associated with lipid goal attainment among acute coronary syndrome patients.  - patient preference and adherence.  1631-1637. 

sunitha esther raj, lee mei tan, adyani md redzuan.  (2016).  dietary salt intake: history, assessment, and benefit in hypertensive treatment.  - asian journal of pharmaceutical and clinical research.  1-4. 

adyani md redzuan, meng lee soon, noraida mohamed shah.  (2014).  adherence to preventive medications in asthmatic children at a tertiary care teaching hospital in malaysia.  - patient preference and adherence.  8:263-270. 

jian lynn lee, adyani md redzuan & noraida mohamed shah.  (2013).  unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in malaysia.  - international journal of clinical pharmacy.  35(6):1025-1029.